IGFBP-3 binding to endothelial cells inhibits plasmin and thrombin proteolysis

American Journal of Physiology - Endocrinology and Metabolism

Volumn 282, Issue 1 45-1, 2002, Pages

  Booth, B A ^a   Boes, M ^a   Dake, B L ^a   Knudtson, K L ^a   Bar, R S ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

IGFBP proteases

Indexed keywords

HEPARIN; IODINE 125; PLASMIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; THROMBIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CHIMERA; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYMATIC DEGRADATION; ENZYME ACTIVITY; ENZYME MECHANISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; VASCULAR ENDOTHELIUM;

EID: 0036073586     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2002.282.1.e52     Document Type: Article

References (26)

1. Recombinant human insulin-like growth factor binding protein-3 stimulates prostate carcincoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases
2. Cultured capillary endothelial cells from bovine adipose tissue: A model for insulin binding and action in microvascular endothelium
3. Insulin-like growth factor (IGF)-binding proteins: Interactions with IGFs and intrinsic bioactivities
4. In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells
5. IGFBP-3 and IGFBP-5 association with endothelial cells: Role of C-terminal heparin binding domain
6. IGFBP-3 proteolysis by plasmin, thrombin, serum: Heparin binding, IGF binding, and structure of fragments
7. Isolation and charcterization of plasmin-generated bioactive fragments of IGFBP-3
8. Plasmin degradation of insulin-like growth factor-binding protein-5 (IGFBP-5): Regulation by IGFBP-5-(201-218)
9. Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3
10. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D
11. Biological effects of prostate-specific antigen as an insulin-like growth factor binding protein-3 protease
12. Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells
13. The heparin binding domain of insulin-like growth factor binding protein (IGFBP)-3 increases susceptibility of IGFBP-3 to proteolysis
14. Insulin-like growth factor binding proteins: New proteins, new functions
15. Structural determinants of ligand and cell-surface-binding on insulin-like growth factor binding protein-3
16. Proteolysis of insulin-like growth factor binding protein-3 during rat pregnancy: A role for matrix metalloproteinases
17. Nuclear localization of insulin-like growth factor binding protein-3 in a lung cancer cell line
18. Distribution of chimeric IGF binding protein (IGFBP)-3 and IGFBP-4 in the rat heart: Importance of C-terminal basic region
19. Proteolysis of insulin-like growth factor binding proteins by a novel 50-kilodalton metalloproteinase in human pregnancy serum
20. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells
21. Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells
22. Insulin-like growth factor binding protein (IGFBP) proteolysis: Occurrence, identification, role and regulation
23. Use of lanthanum to accurately quantify insulin-like growth factor binding to proteins on cell surfaces
24. Insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells
25. Insulin-like growth factor-binding protein 5 complexes with the acid labile subunit: Role of the carboxy-terminal domain
26. Insulin-like growth factor-binding protein-5 is cleaved by physiological concentrations of thrombin